FINHUB Insights

ZTS · Q1 FY26 · Jan 1 – Mar 31, 2026

Zoetis Q1 FY26: where the revenue came from and where it went

Zoetis Q1 FY26: revenue $2.3B (+3% year over year). Net profit $0.6B. Largest cohort Livestock $0.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2026
Reported
May 7, 2026 10-Q
Sankey diagram of Zoetis's income statement for Q1 FY26: revenue of $2.3 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.3B +3% year over year
Gross profit$1.6B 72% margin
Operating profit$0.7B 33% margin
Net profit$0.6B 27% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 2.3 100% +3%
Livestock 0.7 30%
Dermatology 0.3 13%
Other 0.3 13%
Anti Infective Products 0.2 9% +1%
Pain Sedation 0.2 9%
Other Pharmaceuticals 0.2 9% +0%
Swine 0.1 4% +17%
Poultry 0.1 4%
Cost of revenue−0.626%
Gross profit1.672% margin+0pp
SG&A−0.626%+0pp
Other−0.313%+0pp
Operating profit0.733% margin−2pp
Tax−0.1
Net profit0.627%−1pp
Filing on EDGAR More quarters of ZTS

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters